Prognostic significance of the deleted in colorectal cancer gene protein expression in high-risk resected gastric carcinoma

Cancer Investigation

Volumn 21, Issue 3, 2003, Pages 333-340

  Bamias, Aristotle T ^a   Bai, Maria C ^a   Agnantis, Niki J ^a   Michael, Michael C ^a   Alamanos, Yiannis P ^b   Stefanaki, Stella V ^b   Razi, Evagelia D ^c   Skarlos, Dimosthenis V ^d   Kappas, Angelos M ^a   Pavlidis, Nicholas A ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b Ioannina General Hospital   (Greece)

^c HYGEIA HOSPITAL   (Greece)

^d Iatriko Medical Center   (Greece)

Author keywords

DCC; Gastric cancer; Immunohistochemistry; PCNA; Prognosis

Indexed keywords

CYCLINE; DELETED IN COLORECTAL CANCER PROTEIN; GENE PRODUCT; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CELL PROLIFERATION; CHROMOSOME 18Q; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DELETED IN COLORECTAL CANCER GENE; FEMALE; GENE; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SIGNET RING CARCINOMA; STOMACH CARCINOMA; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; AGED; CELL ADHESION MOLECULES; CHROMOSOMES, HUMAN, PAIR 18; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RECEPTORS, CELL SURFACE; RECURRENCE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TIME FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0041857806     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120018219     Document Type: Article

References (35)

1. Alexander, H.R.; Kelsen, D.P.; Tepper, J.E. Cancer of the stomach. In Cancer. Principles and Practice of Oncology, 5th Ed.; DeVita, V.T., Hellman, S., Rosenberg, S.A., Eds.; Lippincot-Raven Publishers: Philadelphia, 1997; 1021-1053.
2. McKean-Cowdin, R.; Feigelson, H.S.; Ross, R.K.; Pike, M.C.; Henderson, B.E. Declining cancer rates in the 1990s. J. Clin. Oncol. 2000, 18, 2258-2268.
3. Bamias, A.; Pavlidis, N. Systemic chemotherapy in gastric cancer. Where do we stand today? Oncologist 1998, 3, 171-177.
4. Fuchs, C.S.; Mayer, R.J. Gastric carcinoma. N. Engl. J. Med. 1995, 333 (1), 32-41.
5. Kelsen, D.P. Adjuvant and neoadjuvant therapy for gastric cancer. Semin. Oncol. 1996, 23 (3), 379-389.
6. Gossios, K.; Tsianos, E.V.; Nicolson, V.; Bamias, A.; Cunningham, D.; Husband, J. CT evaluation of the resectability of gastric cancer postchemotherapy. Abdom. Imaging 1996, 21, 293-298.
7. Joypaul, B.V.; Hopwood, D.; Newman, E.L.; Qureshi, S.; Grant, A.; Ogston, S.A.; Lane, D.P.; Cuschieri, A. The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma. Br. J. Cancer 1994, 69, 943-946.
8. Allgayer, H.; Babic, R.; Gruetzner, K.U.; Tarabichi, A.; Schildberg, F.W.; Heiss, M.M. C-erb-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems. J. Clin. Oncol. 1999, 18, 2201-2209.
9. Cho, K.R.; Fearon, E.R. DCC: Linking tumor suppressor genes and altered cell surface interactions in cancer? Eur. J. Cancer 1995, 31A (7/8), 1055-1060.
10. Uchino, S.; Tsuda, H.; Noguchi, M.; Yokota, J.; Terada, M.; Saito, T.; Kobayashi, M.; Sugimura, T.; Hirobashi, S. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res. 1992, 52, 3099-3102.
11. Fang, D.C.; Jass, J.R.; Wang, D.X. Loss of heterozygosity and loss of expression of the DCC gene in gastric cancer. J. Clin. Pathol. 1998, 51, 593-596.
12. Cropp, C.S.; Lidereau, R.; Campbell, G.; Champene, M.H.; Callahan, R. Loss of heterozygosity on chromosome 17 and 18 in breast carcinoma: two additional regions identified. Proc. Natl Acad. Sci. USA 1990, 87, 7737-7741.
13. Gao, X.; Honn, K.V.; Grignon, D.; Sakr, W.; Chen, Y.Q. Frequent loss of expression and loss of heterozygosity of putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res. 1993, 53, 2723-2727.
14. Peng, H.Q.; Bailey, D.; Bronson, D.; Goss, P.D.; Hong, D. Loss of heterozygosity of tumor suppressor genes in testis cancer. Cancer Res. 1995, 55, 2871-2875.
15. Shibata, D.; Reale, M.A.; Lavin, P.; Silverman, M.; Fearon, E.R.; Steele, G.; Jessup, J.M.; Loda, M.; Summerhayes, I.C. The DCC protein and prognosis in colorectal cancer. N. Engl. J. Med. 1996, 335, 1727-1732.
16. Sun, X.F.; Rutten, S.; Zhang, H.; Nordenskjold, B. Expression of the deleted in colorectal cancer gene is related to prognosis in DNA diploid and low proliferative colorectal adenocarcinoma. J. Clin. Oncol. 1999, 17, 1745-1750.
17. Armitage, P.; Berry, G. Statistical Methods in Medical Research; Blackwell Scientific Publications: Oxford, United Kingdom, 1994.
18. Kaplan, E.; Meirer, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958, 53, 457-481.
19. Cox, D.R. Regression models and life tables. J. R. Stat. Soc. B 1972, 34, 187-220.
20. Vogelstein, B.; Fearon, E.R.; Hamilton, S.R.; Kern, S.E.; Preisinger, A.C.; Leppert, M.; Nakamura, Y.; White, R.; Smits, A.M.; Bos, J.L. Genetic alterations during colorectal cancer development. N. Engl. J. Med. 1988, 319, 453-456.
21. Cho, K.R.; Oliner, J.D.; Simons, J.W.; Hedrick, L.; Fearon, E.R.; Preisinger, A.C.; Hedge, P.; Silverman, G.A.; Vogelstein, B. The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics 1994, 19, 525-531.
22. Hohne, M.W.; Halatsch, M.E.; Kahl, G.F.; Weinel, R.G. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res. 1992, 52, 2616-2619.
23. Murty, V.V.; Li, R.G.; Houldsworth, J.; Bronson, D.L.; Reuter, V.E.; Bosl, G.J.; Chaganti, R.S. Frequent allelic deletions and loss of expression characterize the DCC gene in male germ cell tumors. Oncogene 1994, 9, 3227-3331.
24. Hedrick, L.; Cho, K.R.; Fearon, E.R.; Wu, T.C.; Kinzler, K.W.; Vogelstein, B. The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Dev. 1994, 8, 1174-1183.
25. Turley, H.; Pezella, F.; Kocialkowski, S.; Conley, M.; Kaklamanis, L.; Fawcett, J.; Simmons, D.; Harris, A.L.; Gather, K.C. The distribution of the deleted in colon cancer (DCC) protein in human tissues. Cancer Res. 1995, 55, 5628-5631.
26. Gotley, D.C.; Reeder, J.A.; Fawcett, J.; Walsh, M.D.; Bates, P.; Simmons, D.L.; Antalis, T.M. The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases. Oncogene 1996, 13, 787-795.
27. Fang, D.C.; Jass, J.; Wang, D.X.; Zhou, X.D.; Luo, Y.H.; Young, J. Infrequent loss of heterozygosity of APC/MCC and DCC genes in gastric cancers showing DNA microsatellite instability. J. Clin. Pathol. 1999, 52, 504-508.
28. Battifora, H. P53 immunohistochemistry: a word of caution. Hum. Pathol. 1994, 25 (5), 435-437.
29. Baas, I.O.; Mulder, J.W.; Offerhaus, G.J.; Vogelstein, B.; Hamilton, S.R. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J. Pathol. 1994, 172, 5-12.
30. Yonemura, Y.; Kimura, H.; Fushida, S.; Tugawa, K.; Nakai, Y.; Kaji, M.; Fonseca, L.; Yamaguchi, A.; Miyazaki, I. Analysis of proliferative activity using anti-proliferating cell nuclear antigen antibody in gastric cancer tissue specimens obtained by endoscopic biopsy. Cancer 1993, 71, 2448-2453.
31. Kakeji, Y.; Maehara, Y.; Adachi, Y.; Baba, H.;Mori, M.; Furusawa, M.; Sugimachi, K. Proliferative activity as a prognostic factor in Bormann type 4 gastric carcinoma. Br. J. Cancer 1994, 69, 749-753.
32. Maeda, K.; Chung, Y.S.; Takatsuka, S.; Ogawa, Y.; Onoda, N.; Sawada, T.; Kato, Y.; Nitta, A.; Arimoto, Y.; Kondo, Y.; Sowa, M. Tumor angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma. Br. J. Cancer 1995, 72, 319-323.
33. Jen, J.; Kim, H.; Piantadosi, S.; Liu, Z.F.; Levitt, R.C.; Sistonen, P.; Kinzler, K.W.; Vogelstein, B.; Hamilton, S.R. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N. Engl. J. Med. 1994, 331, 213-221.
34. Howe, J.R.; Roth, S.; Ringold, J.C.; Summers, R.W.; Jarvinen, H.J.; Sistonen, P.; Tomlinson, I.P.; Houlston, R.S.; Bevan, S.; Mitus, F.A.; Stone, E.M.; Aaltonen, L.A. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998, 280, 1086-1088.
35. Blobe, G.C.; Schiemann, W.P.; Lodish, H.F. The role of transforming growth factor a in human disease. N. Engl. J. Med. 2000, 342, 1350-1359.